INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,584 | +144.6% | 409,183 | +45.8% | 0.03% | +146.2% |
| Q2 2023 | $3,100 | -43.6% | 280,561 | -31.5% | 0.01% | -45.8% |
| Q1 2023 | $5,497 | +13.5% | 409,593 | +4.5% | 0.02% | 0.0% |
| Q4 2022 | $4,843 | -99.7% | 391,853 | +290.2% | 0.02% | +200.0% |
| Q3 2022 | $1,399,000 | +1065.8% | 100,436 | +1054.0% | 0.01% | +700.0% |
| Q2 2022 | $120,000 | -93.3% | 8,703 | -92.1% | 0.00% | -85.7% |
| Q1 2022 | $1,785,000 | -13.1% | 109,813 | -13.0% | 0.01% | -12.5% |
| Q4 2021 | $2,055,000 | +71.1% | 126,232 | +109.9% | 0.01% | +60.0% |
| Q2 2021 | $1,201,000 | +1868.9% | 60,136 | +2320.9% | 0.01% | – |
| Q4 2020 | $61,000 | – | 2,484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |